Back
Henlius Shares Advance Amid Reports of Cancer Drug Licensing Discussions with Major Pharma
Back
Stock News
Themes
Henlius Shares Advance Amid Reports of Cancer Drug Licensing Discussions with Major Pharma
CAR-T Therapy
Henlius Shares Advance Amid Reports of Cancer Drug Licensing Discussions with Major Pharma
Edgen Stock
·
Sep 18 2025, 11:00
Share to
Share to
Copy link
source:
[1] Fosun's Henlius in talks with Johnson & Johnson, Roche on cancer drug
[2] Big Pharma Eyes China: J&J And Roche Reportedly In Talks For Henlius' Experimental Cancer Drug - Stocktwits
[3] 10 oncology deals in 2025 spotlight where industry leaders are betting big - Labiotech.eu
Edgen Stock·Sep 18 2025, 11:00Edgen Stock·Sep 18 2025, 11:00
Edgen Stock·Sep 18 2025, 11:00